Evidence map›Paper›PMID 19406949›Full record

ArticleEndocrinology2009

Insulin-like growth factor type 1 receptor and insulin receptor isoform expression and signaling in mammary epithelial cells.

Anne M Rowzee, Dale L Ludwig, Teresa L Wood

Open access · greenAbstract read
In one paragraph

Article in Endocrinology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Human and mouse muscle transcriptomic analyses identify insulin receptor mRNA downregulation in hyperinsulinemia-associated insulin resistance.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. The insulin receptor plays an important role in secretory differentiation in the mammary gland.American journal of physiology. Endocrinology and metabolism · 2013
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Anne M RowzeeDepartment of Neurology and Neuroscience, University Hospital Cancer Center, New Jersey Medical School/University of Medicine and Dentistry of New Jersey, Newark, New Jersey 07101, USA.
Dale L Ludwig
Teresa L Wood
Eli Lilly (United States) · USRutgers New Jersey Medical SchoolUniversity Hospital, Newark · US

Funding

IGF and IGF Receptor Function in Mammary DevelopmentR01DK060612 · NIDDK · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI WOOD, TERESA L · 2002 to 2011
$2.8M
NIDDK NIH HHS DK-060612NIDDK NIH HHS R01 DK060612
6 · The paper itself

Abstract

The insulin receptor (IR) isoforms and the IGF type 1 receptor (IGF-1R) share a high degree of structural homology but differ in ligand binding kinetics and functions. We developed a highly specific quantitative PCR assay to quantify and compare IR-A, IR-B, and IGF-1R expression within an RNA population. We determined receptor expression in primary murine mammary epithelial cells (MECs) during postnatal development. Both IR isoform mRNAs were 3- to 16-fold higher than IGF-1R expression at all developmental times. IR protein was also 3- to 10-fold higher than IGF-1R protein; however, significantly less IGF-1R was found in hybrid receptors at early (49%) vs. late (79%) pregnancy, indicating that the amount of hybrid receptor is developmentally regulated. Despite high IR expression, IGF ligands were more effective than insulin in stimulating the insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt pathway in acutely isolated MECs from virgin glands. Although approximately 40% of IR transcripts were the IGF-II-sensitive IR-A isoform, IGF-II failed to stimulate IR phosphorylation, and an IGF-1R-specific blocking antibody completely abrogated IGF-II-mediated Akt phosphorylation in the virgin MECs. Taken together, these data suggest that the IGF-1R is more active in signaling than the IR and is the predominant mediator of IGF actions in virgin MECs.

Indexed as

Gene Expression Regulation, DevelopmentalSignal TransductionAnimalsBlotting, WesternCells, CulturedDNA, ComplementaryEnzyme-Linked Immunosorbent AssayEpithelial CellsFemaleHypoglycemic AgentsInsulinInsulin-Like Growth Factor IInsulin-Like Growth Factor IIMicePhosphorylationPolymerase Chain ReactionDNA, ComplementaryHypoglycemic AgentsInsulinInsulin-Like Growth Factor IInsulin-Like Growth Factor IIProto-Oncogene Proteins c-aktReceptor, IGF Type 1Receptor, InsulinRNA, Messenger

Identifiers

PMID19406949
PMCPMC2717875
OpenAlexW2038318651

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.